Ensuring Equitable Use of New Genetic Technologies: Lessons from Eugenics
ELSI Friday Forum • January 14, 2022
New genetic technologies have incrementally but steadily altered the landscape of human reproduction. These technologies include polygenic risk scores coupled with embryo selection, fetal testing using DNA sequencing or non-invasive prenatal testing, and reproductive carrier screening. However, the broad use of and access to these new technologies is subject to little evaluation, control or oversight in terms of whether they are serving society’s interests or inflicting social harm. The potential for exacerbating existing inequities or creating new ones is particularly concerning. In this session, panelists will bring perspectives from history, social science and philosophy to start a discussion on lessons learned from empirical and conceptual analysis of eugenics, and how we can employ them in an era of rapid growth of new genetic technologies.
Panelist: Emily Klancher Merchant, PhD (University of California, Davis)
Panelist: Lisa Dive, PhD (University of Sydne
Moderator: Osagie Obasogie, JD, PhD (University of California, Berkeley)
Please see the attached transcript and resources files in the upper right hand corner of this page for more information on this topic, as well as the ELSIhub Collection "Social Norms in Selective Reproduction: Implications for the Wide Offer of Genetic Screening Technologies"
Tags
Videos in Series
-
ELSI Friday Forum - The Genomics of PTSD Risk: Scientific and Ethical Perspectives
-
ELSI Friday Forum - Population Descriptors in Genomic Research: Applying the NASEM Recommendations
-
ELSI Friday Forum - Legal and Policy Challenges to Privacy in the Post-Genomic and Post-Dobbs Era
-
ELSI Friday Forum - Value and Values in Payment for Gene Therapies
-
ELSI Friday Forum - Visual Storytelling in ELSI Research
-
ELSI Friday Forum - Indigenizing Genomics and Advancing Indigenous Data Sovereignty
-
ELSI Friday Forum - Wrestling with Social and Behavioral Genomics
-
ELSI Friday Forum - Genetic Advantages in Sports: When Do They Count as "Doping"?
-
ELSI Friday Forum - Genetics and AI: Group Privacy and Fairness
-
ELSI Friday Forum - Advocacy and Allyship in ELSI: Opportunities and Challenges
-
ELSI Friday Forum - Decoloniality and Genetic Ancestry: Situating the "African Genome"
-
ELSI Friday Forum - Legal Challenges to Newborn Screening Research
-
ELSI Friday Forum - Impact of SCOTUS's Dobbs Decision on Prenatal Genomics Research and Practice
-
ELSI Friday Forum - Addressing Algorithmic Harms: Practices and Provocations for Health AI
-
ELSI Friday Forum - Balancing Data Privacy and Data Sharing: Normative and Technical Approaches
-
ELSI Friday Forum - Genomic Imaginaries: Sparking Dialogue between ELSI and Literary Studies
-
ELSI Friday Forum - New ACMG Guidance on Carrier Screening: More or Less Equitable?
-
ELSI Friday Forum - Benefit-sharing and Pharmaceutical Development in Africa: What Does Equity Mean?
-
ELSI Friday Forum - Genomic Data Sharing: Putting Principles and Policy into Practice
-
ELSI Friday Forum - Current Legal Challenges to Abortion: Implications for Prenatal Genetics
-
ELSI Friday Forum - Ethical Challenges in Novel Gene Therapies for Sickle Cell Disease
-
ELSI Friday Forum - Widening the Lens: Using Arts in ELSI Research
-
ELSI Friday Forum - Migrant DNA: Context, Ethics and Legal Issues
-
ELSI Friday Forum - Genomics and Infectious Disease: Scientific and ELSI Issues of COVID
-
ELSI Friday Forum - ELSI Friday Forum: Biobanking in the Era of COVID
-
ELSI Friday Forum - Addressing Racism in Research and Clinical Practice
-
ELSI Friday Forum - ELSI Friday Forum: Structural Racism and Genomics in the Time of COVID